20 Largest U.S. Companies By Market Capitalization
Large Caps » By The Online Investor Staff, updated Mon., Feb. 6, 1:26 AM
| Large Caps: #1 of 20 |
#20. Lilly (Eli) & Co (NYSE:LLY) — $322.19B
Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products and other therapies. Co.'s diabetes products include: Basaglar®, a long-acting human insulin analog for the treatment of diabetes; and Trajenta®, for the treatment of type 2 diabetes. Co.'s oncology products include: Alimta®, for treatment of patients with non-squamous cell histology and no epidermal growth factor receptor or anaplastic lymphoma kinase genomic tumor aberrations.
Eli Lilly SEC Filing Email Alerts Service
Open the LLY Page at The Online Investor »
Jump to: Most Valuable Company In The World
|
||||||||||||||||||
Open the LLY Page at The Online Investor (in a new window) »
List of Large Caps in this Slideshow: Large Cap Company Ticker Market Cap ($in billions) Apple Inc AAPL 2446.69 Microsoft Corporation MSFT 1923.07 Amazon.com Inc AMZN 1054.75 Alphabet Inc GOOG 640.37 Alphabet Inc GOOGL 625.85 Tesla Inc TSLA 601.12 NVIDIA Corp NVDA 525.39 Exxon Mobil Corp XOM 460.92 UnitedHealth Group Inc UNH 441.03 Johnson & Johnson JNJ 430.37 Meta Platforms Inc META 420.68 JPMorgan Chase & Co JPM 413.85 Berkshire Hathaway Inc BRK.B 401.67 Walmart Inc WMT 382.16 Visa Inc V 373.95 Mastercard Inc MA 356.64 Home Depot Inc HD 339.37 Procter & Gamble Company (The) PG 336.44 Chevron Corporation CVX 327.66 Lilly (Eli) & Co LLY 322.19
 Free LLY Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Strong Buy (3.72 out of 4) 67th percentile
(ranked higher than approx. 67% of all stocks covered)
Analysts' Target Price: LLY Stock Forecast Based on Zacks ABR data; powered by Xignite |
